Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives
Frontiers in Bioscience-Landmark · 25.05.2023 · 28 (5)
DOI: 10.31083/j.fbl2805103 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 25.05.2023. Verfasst von Riccardo Nevola und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli'', 80138 Naples, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sodium-glucose co-transporters (SGLTs) family members are involved in several vital biological functions. Except for SGLT3, they are involved in the mechanisms of active transport of sodium and glucose and several micromolecules. The discovery of functions and mechanisms of SGLT1 inhibition and, in particular, of SGLT2 has radically changed the natural history of some pathologies. SGLT2 inhibitors have revolutionized the therapeutic approach not only of type 2 diabetes mellitus but also of heart failure and chronic kidney failure. Considering the role played by the other SGLTs and the functions still unknown to date, clinical implications of the inhibition of SGLT2 could represent the prelude for a wider modulation of these cotransporters. A better understanding of the role and function of SGLTs could represent a revolution in the therapeutic approach in the hepatological, metabolic, neurological and oncological fields. The purpose of this review is to illustrate the knowledge currently available on SGLTs, its clinical implications and future perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli'', 80138 Naples, Italy.
- Internal Medicine and Hepatology Unit, Ospedale Evangelico Betania, 80147 Naples, Italy.
- Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', 80138 Naples, Italy.
Zitieren
APA
Nevola, R., Villani, A., Imbriani, S., Alfano, M., Criscuolo, L., Beccia, D., Ruocco, R., Femine, A. D., Gragnano, F., Cozzolino, D., Marfella, R., Adinolfi, L. E., Sasso, F. C., & Rinaldi, L. (2023). Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives. Frontiers in Bioscience-Landmark, 28(5). https://doi.org/10.31083/j.fbl2805103
Vancouver
Nevola R, Villani A, Imbriani S, Alfano M, Criscuolo L, Beccia D, et al. Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives. Frontiers in Bioscience-Landmark. 2023;28(5). doi:10.31083/j.fbl2805103
BibTeX
@article{Nevola2023,
author = {Nevola, Riccardo and Villani, Angela and Imbriani, Simona and Alfano, Maria and Criscuolo, Livio and Beccia, Domenico and Ruocco, Rachele and Femine, Augusto Delle and Gragnano, Felice and Cozzolino, Domenico and Marfella, Raffaele and Adinolfi, Luigi Elio and Sasso, Ferdinando Carlo and Rinaldi, Luca},
title = {Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives},
journal = {Frontiers in Bioscience-Landmark},
year = {2023},
volume = {28},
number = {5},
doi = {10.31083/j.fbl2805103}
}
EUVIMED